3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
zolbetuximab
2
Oxaliplatin
2
Afatinib
2
trastuzumab deruxtecan
1
tepotinib
1
repotrectinib
1
pralsetinib
1
brigatinib
1
Standard of Care
1
Pemetrexed
1
Leucovorin
1
Fluorouracil
1
Crizotinib
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Adenocarcinoma
×
tepotinib
×
Clear all
NCT02864992
2026-04-13
VISION
EMD Serono
Phase 2
Active not recruiting
337 enrolled
13 charts
2 FDA